Timing and Predictors of Recanalization After Anticoagulation in Cerebral Venous Thrombosis.

IF 6 1区 医学 Q1 CLINICAL NEUROLOGY
Journal of Stroke Pub Date : 2023-05-01 Epub Date: 2023-05-30 DOI:10.5853/jos.2023.00213
Setareh Salehi Omran, Liqi Shu, Allison Chang, Neal S Parikh, Adeel S Zubair, Alexis N Simpkins, Mirjam R Heldner, Arsany Hakim, Sami Al Kasab, Thanh Nguyen, Piers Klein, Eric D Goldstein, Maria Cristina Vedovati, Maurizio Paciaroni, David S Liebeskind, Shadi Yaghi, Shawna Cutting
{"title":"Timing and Predictors of Recanalization After Anticoagulation in Cerebral Venous Thrombosis.","authors":"Setareh Salehi Omran, Liqi Shu, Allison Chang, Neal S Parikh, Adeel S Zubair, Alexis N Simpkins, Mirjam R Heldner, Arsany Hakim, Sami Al Kasab, Thanh Nguyen, Piers Klein, Eric D Goldstein, Maria Cristina Vedovati, Maurizio Paciaroni, David S Liebeskind, Shadi Yaghi, Shawna Cutting","doi":"10.5853/jos.2023.00213","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>Vessel recanalization after cerebral venous thrombosis (CVT) is associated with favorable outcomes and lower mortality. Several studies examined the timing and predictors of recanalization after CVT with mixed results. We aimed to investigate predictors and timing of recanalization after CVT.</p><p><strong>Methods: </strong>We used data from the multicenter, international AntiCoagulaTION in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT) study of consecutive patients with CVT from January 2015 to December 2020. Our analysis included patients that had undergone repeat venous neuroimaging more than 30 days after initiation of anticoagulation treatment. Prespecified variables were included in univariate and multivariable analyses to identify independent predictors of failure to recanalize.</p><p><strong>Results: </strong>Among the 551 patients (mean age, 44.4±16.2 years, 66.2% women) that met inclusion criteria, 486 (88.2%) had complete or partial, and 65 (11.8%) had no recanalization. The median time to first follow-up imaging study was 110 days (interquartile range, 60-187). In multivariable analysis, older age (odds ratio [OR], 1.05; 95% confidence interval [CI], 1.03-1.07), male sex (OR, 0.44; 95% CI, 0.24-0.80), and lack of parenchymal changes on baseline imaging (OR, 0.53; 95% CI, 0.29-0.96) were associated with no recanalization. The majority of improvement in recanalization (71.1%) occurred before 3 months from initial diagnosis. A high percentage of complete recanalization (59.0%) took place within the first 3 months after CVT diagnosis.</p><p><strong>Conclusion: </strong>Older age, male sex, and lack of parenchymal changes were associated with no recanalization after CVT. The majority recanalization occurred early in the disease course suggesting limited further recanalization with anticoagulation beyond 3 months. Large prospective studies are needed to confirm our findings.</p>","PeriodicalId":17135,"journal":{"name":"Journal of Stroke","volume":"25 2","pages":"291-298"},"PeriodicalIF":6.0000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e8/30/jos-2023-00213.PMC10250867.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Stroke","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5853/jos.2023.00213","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/5/30 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and purpose: Vessel recanalization after cerebral venous thrombosis (CVT) is associated with favorable outcomes and lower mortality. Several studies examined the timing and predictors of recanalization after CVT with mixed results. We aimed to investigate predictors and timing of recanalization after CVT.

Methods: We used data from the multicenter, international AntiCoagulaTION in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT) study of consecutive patients with CVT from January 2015 to December 2020. Our analysis included patients that had undergone repeat venous neuroimaging more than 30 days after initiation of anticoagulation treatment. Prespecified variables were included in univariate and multivariable analyses to identify independent predictors of failure to recanalize.

Results: Among the 551 patients (mean age, 44.4±16.2 years, 66.2% women) that met inclusion criteria, 486 (88.2%) had complete or partial, and 65 (11.8%) had no recanalization. The median time to first follow-up imaging study was 110 days (interquartile range, 60-187). In multivariable analysis, older age (odds ratio [OR], 1.05; 95% confidence interval [CI], 1.03-1.07), male sex (OR, 0.44; 95% CI, 0.24-0.80), and lack of parenchymal changes on baseline imaging (OR, 0.53; 95% CI, 0.29-0.96) were associated with no recanalization. The majority of improvement in recanalization (71.1%) occurred before 3 months from initial diagnosis. A high percentage of complete recanalization (59.0%) took place within the first 3 months after CVT diagnosis.

Conclusion: Older age, male sex, and lack of parenchymal changes were associated with no recanalization after CVT. The majority recanalization occurred early in the disease course suggesting limited further recanalization with anticoagulation beyond 3 months. Large prospective studies are needed to confirm our findings.

Abstract Image

脑静脉血栓抗凝治疗后再通的时间和预测因素
背景和目的:脑静脉血栓形成(CVT)后血管再通与良好的预后和较低的死亡率相关。一些研究探讨了 CVT 后血管再通的时机和预测因素,但结果不一。我们旨在研究 CVT 后再通畅的预测因素和时机:我们使用了 2015 年 1 月至 2020 年 12 月期间多中心、国际性脑静脉血栓治疗中的抗凝治疗(ACTION-CVT)研究的数据,研究对象为连续的 CVT 患者。我们的分析包括在开始抗凝治疗 30 天后重复接受静脉神经影像学检查的患者。预设变量被纳入单变量和多变量分析,以确定无法再通畅的独立预测因素:在符合纳入标准的 551 例患者(平均年龄为 44.4±16.2 岁,66.2% 为女性)中,486 例(88.2%)完全或部分再通,65 例(11.8%)未再通。首次随访成像研究的中位时间为 110 天(四分位间范围为 60-187)。在多变量分析中,年龄较大(比值比 [OR],1.05;95% 置信区间 [CI],1.03-1.07)、性别为男性(OR,0.44;95% CI,0.24-0.80)以及基线成像没有实质病变(OR,0.53;95% CI,0.29-0.96)与无再通有关。大部分(71.1%)再通的改善发生在最初诊断后的 3 个月之前。高比例的完全再通(59.0%)发生在 CVT 诊断后的头 3 个月内:结论:高龄、男性、实质无变化与 CVT 后无再通有关联。大部分再通均发生在病程早期,这表明抗凝治疗在 3 个月后的再通率有限。我们需要大型前瞻性研究来证实我们的发现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Stroke
Journal of Stroke CLINICAL NEUROLOGYPERIPHERAL VASCULAR DISE-PERIPHERAL VASCULAR DISEASE
CiteScore
11.00
自引率
3.70%
发文量
52
审稿时长
12 weeks
期刊介绍: The Journal of Stroke (JoS) is a peer-reviewed publication that focuses on clinical and basic investigation of cerebral circulation and associated diseases in stroke-related fields. Its aim is to enhance patient management, education, clinical or experimental research, and professionalism. The journal covers various areas of stroke research, including pathophysiology, risk factors, symptomatology, imaging, treatment, and rehabilitation. Basic science research is included when it provides clinically relevant information. The JoS is particularly interested in studies that highlight characteristics of stroke in the Asian population, as they are underrepresented in the literature. The JoS had an impact factor of 8.2 in 2022 and aims to provide high-quality research papers to readers while maintaining a strong reputation. It is published three times a year, on the last day of January, May, and September. The online version of the journal is considered the main version as it includes all available content. Supplementary issues are occasionally published. The journal is indexed in various databases, including SCI(E), Pubmed, PubMed Central, Scopus, KoreaMed, Komci, Synapse, Science Central, Google Scholar, and DOI/Crossref. It is also the official journal of the Korean Stroke Society since 1999, with the abbreviated title J Stroke.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信